Logo image of SLXN

SILEXION THERAPEUTICS CORP (SLXN) Stock Analyst Earnings Estimates

NASDAQ:SLXN - Nasdaq - Common Stock

0.7799  +0.01 (+1.29%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
SLXN revenue by date.SLXN revenue by date.
N/AN/AN/A
EBITDA
YoY % growth
SLXN ebitda by date.SLXN ebitda by date.
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
SLXN ebit by date.SLXN ebit by date.
-200K-770K
-285.00%
-1.11M
-44.16%
-1.101M
0.78%
N/A
-1,054.59%
N/A
-11.25%
N/A
-37.90%
Operating Margin
SLXN operating margin by date.SLXN operating margin by date.
N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
SLXN eps by date.SLXN eps by date.
N/AN/AN/AN/AN/AN/A
48.80%
N/A
-12.50%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 24 Q4 / 24
EPS
Q2Q % growth
0.00-0.11
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/A
EBIT
Q2Q % growth
-8.197M
-5,022.95%
-1.71M
-372.80%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
SLXN Yearly EPS VS EstimatesSLXN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -2 -4 -6 -8 -10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
SLXN Yearly Revenue VS EstimatesSLXN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A